U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07706829) titled 'Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study' on July 01.
Brief Summary: The study aims to provide initial proof-of-concept validation data of an artificial intelligence-based model to estimate individual Parkinson's disease risk using demographic, clinical, genetic information and digital biomarker data collected via a smartwatch and a mobile application.
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
Parkinson Disease (PD)
REM Sleep Behavior Disorder (iRBD)
Neurogenic Orthostatic Hypotension
Hyposmia
Intervention:
DEVICE: Smartwatch and phone app
Wearing a smartwatch and u...